HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shamir R Mehta Selected Research

otamixaban

3/2021Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.
1/2021Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial.
10/2020Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.
10/2020Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.
1/2018Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
11/2017Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).
9/2013Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
12/2012Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shamir R Mehta Research Topics

Disease

73Myocardial Infarction
12/2022 - 02/2003
68Hemorrhage
10/2022 - 02/2003
66Acute Coronary Syndrome
10/2022 - 09/2002
39ST Elevation Myocardial Infarction
12/2021 - 01/2005
38Stroke (Strokes)
12/2022 - 02/2003
23Thrombosis (Thrombus)
01/2021 - 03/2005
18Unstable Angina
10/2022 - 09/2002
16Coronary Artery Disease (Coronary Atherosclerosis)
12/2022 - 01/2014
9Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 09/2004
8Atrial Fibrillation
11/2020 - 05/2010
7Diabetes Mellitus
12/2022 - 04/2009
7Heart Failure
01/2022 - 01/2005
6Ischemia
07/2009 - 12/2004
5Type 2 Diabetes Mellitus (MODY)
12/2022 - 05/2019
3Renal Insufficiency (Renal Failure)
12/2021 - 07/2015
3Death (Near-Death Experience)
01/2021 - 03/2017
3Infarction (Infarctions)
01/2019 - 02/2008
2Chronic Renal Insufficiency
08/2022 - 04/2007
2Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2022 - 10/2019
2Coronary Disease (Coronary Heart Disease)
10/2019 - 05/2019
2Pathologic Constriction (Stenosis)
09/2019 - 05/2019
2Cardiogenic Shock
11/2018 - 10/2017
2Non-ST Elevated Myocardial Infarction
11/2017 - 01/2005
2Body Weight (Weight, Body)
02/2017 - 04/2006
2Hypoglycemia (Reactive Hypoglycemia)
01/2012 - 12/2009
2Venous Thrombosis (Deep-Vein Thrombosis)
12/2005 - 03/2005
1MINOCA
11/2021
1Hematoma
01/2021
1AIDS-Related Complex (ARC)
01/2020
1Weight Gain
04/2017
1Inflammation (Inflammations)
03/2017

Drug/Important Bio-Agent (IBA)

35Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022 - 09/2002
32Clopidogrel (Plavix)FDA Link
10/2022 - 09/2002
24TicagrelorIBA
12/2022 - 11/2013
17Fondaparinux (Arixtra)FDA Link
04/2015 - 03/2005
15Heparin (Liquaemin)FDA LinkGeneric
03/2021 - 01/2005
112'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
08/2022 - 10/2015
10Glucose (Dextrose)FDA LinkGeneric
11/2020 - 12/2004
9Enoxaparin (Lovenox)FDA LinkGeneric
07/2009 - 12/2005
8otamixabanIBA
03/2021 - 12/2012
7TroponinIBA
11/2020 - 01/2017
7AnticoagulantsIBA
01/2020 - 04/2006
6Prasugrel HydrochlorideFDA Link
08/2022 - 11/2013
6omega-Chloroacetophenone (Mace)IBA
08/2022 - 10/2016
6Eptifibatide (Integrilin)FDA Link
03/2021 - 12/2012
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2022 - 04/2006
5Troleandomycin (TAO)FDA Link
03/2021 - 09/2013
5trans-crotonin (CTN)IBA
11/2020 - 01/2017
5Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2006
5Insulin (Novolin)FDA Link
01/2012 - 12/2004
4Biomarkers (Surrogate Marker)IBA
11/2020 - 11/2016
4PolymersIBA
01/2020 - 04/2015
4Factor Xa InhibitorsIBA
10/2011 - 03/2005
4PotassiumIBA
12/2009 - 12/2004
4Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2009 - 12/2004
3ElementsIBA
01/2019 - 04/2015
3Varenicline (Chantix)FDA Link
01/2018 - 01/2016
2Purinergic P2Y Receptor AntagonistsIBA
06/2021 - 12/2016
2Warfarin (Coumadin)FDA LinkGeneric
11/2020 - 01/2017
2Troponin IIBA
06/2020 - 01/2018
2MetalsIBA
01/2020 - 02/2017
2LipidsIBA
01/2020 - 01/2019
2TenecteplaseFDA Link
02/2018 - 10/2017
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2015 - 01/2005
2CreatinineIBA
07/2015 - 08/2006
2Cytochrome P-450 CYP2C19IBA
09/2012 - 10/2010
2Platelet Membrane Glycoprotein IIbIBA
12/2009 - 07/2009
2Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2009 - 02/2008
2A-factor (Streptomyces)IBA
04/2006 - 12/2005
2Factor Xa (Coagulation Factor Xa)IBA
12/2005 - 03/2005
2ThrombinFDA Link
12/2005 - 03/2005
2reviparin (reviparin-sodium)IBA
01/2005 - 12/2004
1salicylhydroxamic acid (SHAM)IBA
01/2022
1high fluorescent intermediate IIIBA
01/2022
1DabigatranFDA Link
11/2020
1Pharmaceutical PreparationsIBA
01/2020
1CholesterolIBA
01/2020
1Opioid Analgesics (Opioids)IBA
01/2019
1EverolimusFDA Link
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1Biological ProductsIBA
10/2018
1APTIBA
01/2018
1SmokeIBA
01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2017
1Antihypertensive Agents (Antihypertensives)IBA
04/2017
1Purinergic P2 Receptors (ADP Receptor)IBA
02/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2017

Therapy/Procedure

66Percutaneous Coronary Intervention
12/2022 - 02/2003
56Therapeutics
10/2022 - 12/2002
20Stents
01/2021 - 05/2010
12Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2021 - 02/2011
5Drug-Eluting Stents
01/2021 - 04/2015
5Thrombolytic Therapy
10/2017 - 01/2006
4Thrombectomy
01/2019 - 07/2009
3Secondary Prevention
10/2022 - 11/2013
3Catheters
12/2018 - 10/2007
2Length of Stay
03/2015 - 06/2014
2Conservative Treatment
09/2012 - 11/2008
1Surgical Amputation (Amputations)
01/2022
1Transcatheter Aortic Valve Replacement
01/2018